NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free CRON Stock Alerts $2.23 +0.13 (+6.19%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$2.08▼$2.2450-Day Range$1.93▼$2.3052-Week Range$1.64▼$2.64Volume3.77 million shsAverage Volume1.81 million shsMarket Capitalization$850.30 millionP/E RatioN/ADividend YieldN/APrice Target$2.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Cronos Group alerts: Email Address Cronos Group MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside19.6% Upside$2.67 Price TargetShort InterestHealthy3.25% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.54Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.01) to $0.03 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.20 out of 5 starsMedical Sector803rd out of 946 stocksMedicinals & Botanicals Industry9th out of 11 stocks 2.2 Analyst's Opinion Consensus RatingCronos Group has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.67, Cronos Group has a forecasted upside of 19.6% from its current price of $2.23.Amount of Analyst CoverageCronos Group has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.25% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cronos Group has recently decreased by 2.85%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRON. Previous Next 2.5 News and Social Media Coverage News SentimentCronos Group has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Cronos Group this week, compared to 2 articles on an average week.Search InterestOnly 9 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat Follows14 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is an increase of 56% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.96% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 8.63% of the stock of Cronos Group is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.01) to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -11.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -11.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Monument Traders AllianceMake This $3 Trade the Instant the Opening Bell RingsSince the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…See Why This $3.00 Stock Could Hit $15.00 About Cronos Group Stock (NASDAQ:CRON)Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More CRON Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRON Stock News HeadlinesMarch 18, 2024 | seekingalpha.comCronos Group Inc. (CRON) Roth MKM 36th Annual ROTH Conference (Transcript)March 18, 2024 | seekingalpha.comAltria: Still Undervalued, Buy On StrengthMarch 19, 2024 | Crypto 101 Media (Ad)Like Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. March 17, 2024 | americanbankingnews.comCronos Group (NASDAQ:CRON) Trading Up 3.5%March 14, 2024 | msn.comDr Boreham’s Crucible: Vitura Health is the tall poppy in a paddock of weedMarch 13, 2024 | investorplace.comThe 3 Most Undervalued Stocks to Buy for Under $5 in March 2024March 12, 2024 | globenewswire.comCronos Group Inc. to Speak at the 36th Annual Roth ConferenceMarch 11, 2024 | investorplace.comBudding Millionaires: 3 Cannabis Stocks With 5-Bagger Potential by 2025March 19, 2024 | Weiss Ratings (Ad)The ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …March 8, 2024 | investorplace.comFrom Zero to Hero: 7 Penny Stocks Set for a Decade of DominanceMarch 4, 2024 | finance.yahoo.comCronos Group Full Year 2023 Earnings: Misses ExpectationsMarch 4, 2024 | seekingalpha.comCronos Stock: Attractive Now With Cannabis Legalization In GermanyFebruary 29, 2024 | msn.comMarijuana Company Cronos Reduces FY23 Net Loss As It Utilizes Global ExpansionFebruary 29, 2024 | finance.yahoo.comCronos Group Inc (CRON) Posts Mixed 2023 Financial Results Amidst Global ExpansionFebruary 29, 2024 | globenewswire.comCronos Group Reports 2023 Fourth Quarter and Full-Year Results¹February 20, 2024 | barrons.comInvestigators Disrupt 'Most Harmful Cyber Crime Group'February 20, 2024 | investorplace.com3 Cannabis Stocks That Could Be Multibaggers in the Making: February EditionFebruary 20, 2024 | investorplace.com3 Millionaire-Maker Cannabis Penny Stocks to Buy in February 2024February 20, 2024 | msn.com‘World’s most harmful’ cybercriminal group disrupted in 11-nation operationFebruary 20, 2024 | msn.comHacker group's site taken over by law enforcementFebruary 20, 2024 | msn.comInternational intelligence services conducted operation against cybercriminals from LockbitFebruary 19, 2024 | theguardian.comProlific cybercrime gang disrupted by joint UK, US and EU operationFebruary 19, 2024 | investorplace.com3 Stocks Under $10 for 10-Bagger Returns by 2030February 17, 2024 | finance.yahoo.comCRON Mar 2024 3.000 callFebruary 16, 2024 | finance.yahoo.comCRON Jan 2025 5.500 putFebruary 15, 2024 | msn.comWhy I Won't Touch This Nearly 10% Yielding Dividend Stock With a 10-Foot PoleFebruary 14, 2024 | globenewswire.comCronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024See More Headlines Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/29/2024Today3/19/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolNASDAQ:CRON CUSIPN/A CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees356Year FoundedN/APrice Target and Rating Average Stock Price Target$2.67 High Stock Price Target$3.00 Low Stock Price Target$2.00 Potential Upside/Downside+19.6%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,960,000.00 Net Margins-84.15% Pretax Margin-84.44% Return on Equity-3.99% Return on Assets-3.87% Debt Debt-to-Equity RatioN/A Current Ratio22.54 Quick Ratio21.81 Sales & Book Value Annual Sales$87.24 million Price / Sales9.75 Cash FlowN/A Price / Cash FlowN/A Book Value$2.87 per share Price / Book0.78Miscellaneous Outstanding Shares381,300,000Free Float373,826,000Market Cap$850.30 million OptionableOptionable Beta1.13 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Michael Ryan Gorenstein J.D. (Age 37)President, CEO & Chairman Comp: $3.94MMr. James Holm (Age 41)Chief Financial Officer Comp: $314.31kMr. Jeffrey David Jacobson (Age 38)Chief Growth Officer Comp: $730.12kMs. Anna Shlimak (Age 38)Senior Vice President of Corporate Affairs & Strategy Comp: $530.5kMr. James Andrew McGinness III (Age 45)VP, Controller & Principal Accounting Officer Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyMr. Terry Gregory-Joseph Doucet (Age 34)General Counsel & Corporate Secretary Ms. Shannon Buggy (Age 54)Senior VP & Global Head of People Comp: $438.81kMr. Arye Weigensberg (Age 41)Senior VP & Head of Research and Development More ExecutivesKey CompetitorsUSANA Health SciencesNYSE:USNAbioteNASDAQ:BTMDCanopy GrowthNASDAQ:CGCAurinia PharmaceuticalsNASDAQ:AUPHBicycle TherapeuticsNASDAQ:BCYCView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 124,691 shares on 3/11/2024Ownership: 1.856%Goldman Sachs Group Inc.Sold 197,362 shares on 3/1/2024Ownership: 0.043%Virtu Financial LLCBought 8,701 shares on 2/26/2024Ownership: 0.021%Legal & General Group PlcBought 8,800 shares on 2/15/2024Ownership: 0.041%Wolverine Trading LLCBought 14,600 shares on 2/15/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions CRON Stock Analysis - Frequently Asked Questions Should I buy or sell Cronos Group stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares. View CRON analyst ratings or view top-rated stocks. What is Cronos Group's stock price target for 2024? 3 Wall Street research analysts have issued 1 year price objectives for Cronos Group's stock. Their CRON share price targets range from $2.00 to $3.00. On average, they predict the company's share price to reach $2.67 in the next year. This suggests a possible upside of 19.6% from the stock's current price. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts. How have CRON shares performed in 2024? Cronos Group's stock was trading at $2.09 at the beginning of 2024. Since then, CRON stock has increased by 6.7% and is now trading at $2.23. View the best growth stocks for 2024 here. When is Cronos Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our CRON earnings forecast. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) announced its quarterly earnings results on Thursday, February, 29th. The company reported ($0.05) EPS for the quarter. The company had revenue of $23.92 million for the quarter, compared to the consensus estimate of $25.15 million. Cronos Group had a negative trailing twelve-month return on equity of 3.99% and a negative net margin of 84.15%. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI). Who are Cronos Group's major shareholders? Cronos Group's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (1.86%), Vanguard Group Inc. (1.86%), Dimensional Fund Advisors LP (0.53%), Intact Investment Management Inc. (0.23%), Mirae Asset Global Investments Co. Ltd. (0.18%) and AdvisorShares Investments LLC (0.13%). View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CRON) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThe world’s greatest investmentPorter & CompanySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.